Ballew Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $251K | Buy |
1,325
+6
| +0.5% | +$1.14K | 0.15% | 99 |
|
|
2025
Q1 | $231K | Buy |
+1,319
| New | +$231K | 0.15% | 101 |
|
|
2024
Q4 | – | Sell |
-1,123
| Closed | -$219K | – | 105 |
|
|
2024
Q3 | $219K | Buy |
+1,123
| New | +$219K | 0.15% | 100 |
|
|
2018
Q4 | – | Sell |
-521
| Closed | -$42K | – | 93 |
|
|
2018
Q3 | $42K | Buy |
521
+3
| +0.6% | +$242 | 0.04% | 172 |
|
|
2018
Q2 | $48K | Buy |
518
+3
| +0.6% | +$278 | 0.05% | 158 |
|
|
2018
Q1 | $49K | Buy |
+515
| New | +$49K | 0.04% | 162 |
|